Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL
John R. Davies(St James's University Hospital), David W. Scott(BC Cancer Agency), Laura K. Hilton(BC Cancer Agency), Aixiang Jiang(Simon Fraser University), Sharon Barrans(Leeds Teaching Hospitals NHS Trust), David R. Westhead(University of Leeds), Francesco Cucco(University of Cambridge), Christian Steidl(University of British Columbia), Reuben Tooze(University of Leeds), Matthew A. Care(University of Leeds), Chulin Sha, Andrew Davies(University Hospital Southampton NHS Foundation Trust), Ryan D. Morin(Simon Fraser University), Ming‐Qing Du(MRC Laboratory of Molecular Biology), Catherine Burton(Leeds Teaching Hospitals NHS Trust), Peter Johnson(Cancer Research UK)
Cited by 14
Related Papers
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k